Design and chemical synthesis of a magnetic resonance contrast agent with enhanced in vitro binding, high blood-brain barrier permeability, and in vivo targeting to Alzheimer's disease amyloid plaques.
Biochemistry. 2004 May 25;43(20):6064-75. doi: 10.1021/bi0359574.
Biochemistry. 2004.
PMID: 15147190
Free PMC article.